Subscribe To

Price Alert Latest News Economic Calendar News

AYTU / Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023

ENGLEWOOD, CO / ACCESSWIRE / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, will report financial results for its third quarter fiscal year 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023. The Company has scheduled a conference call that same day, Thursday, May 11, 2023, at 4:30 pm ET, to review the results. Read More

Demo Live Account See Partner Details

Content Topics

AYTU

Biopharma

Report

Third

Quarter

Fiscal

2023

Financial

Results

Stock

Posted: May 4 2023, 16:30

Author Name: Accesswire

AYTU News

By Seeking Alpha
September 27, 2023

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q4 2023 Earnings Call Transcript September 27, 2023 4:30 PM ET Company Participants Robert Blum - IR Josh Disbrow

By Accesswire
September 21, 2023

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

ENGLEWOOD, CO / ACCESSWIRE / September 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on comm

By Seeking Alpha
May 11, 2023

Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q3 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh D

By Accesswire
May 4, 2023

Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023

ENGLEWOOD, CO / ACCESSWIRE / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer

By Seeking Alpha
February 21, 2023

Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q2 2023 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners J

By Accesswire
February 21, 2023

Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023

ENGLEWOOD, CO / ACCESSWIRE / February 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and con

By Seeking Alpha
November 14, 2022

Aytu BioPharma, Inc. (AYTU) Q1 2023 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q1 2023 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Roger Weiss - Lytham Partners J

By Zacks Investment Research
February 18, 2022

Has Aytu BioPharma Inc. (AYTU) Outpaced Other Medical Stocks This Year?

Here is how Aytu BioPharma Inc. (AYTU) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.